Crossmark

Revisiting the molecular mechanism of acquired resistance to reversible tyrosine kinase inhibitors caused by EGFR gatekeeper T790M mutation in non-small-cell lung cancer

Crossref DOI link: https://doi.org/10.1007/s00044-018-2224-7

Published Online: 2018-07-28

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Yan

Jiao, Yingjie

Sun, Fengzhe

Liu, Xudong
License Information

Text and Data Mining valid from 2018-07-28
More Information

Article History

Received: 3 May 2018

Accepted: 19 July 2018

First Online: 28 July 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below